Clinical Trial Search

Primary: Percentage of Patients With a Reduction in Intraocular Pressure (IOP) ≥ 5mmHg From Baseline — 75.9 Millimeters of Mercury (mmHg)

Primary: Change From Baseline in Intraocular Pressure (IOP) in the Right Eye — -4.5 mmHg

Primary: Change From Baseline in Intraocular Pressure (IOP) — 19.0; -4.0; 20.0; -5.0 Millimeters of Mercury (mmHg)

Primary: Change From Baseline in Intraocular Pressure (IOP) — 20.0; -4.0; 20.0; -4.0 Millimeters of Mercury (mmHg)

Primary: Intraocular Pressure (IOP) at Baseline — 21.23; 21.38 Millimeters of Mercury (mmHg)

Primary: Change From Baseline in Intraocular Pressure (IOP) in the Study Eye — 22.18; 16.11 mmHg

Primary: Intra- Examiner Agreement in Angle Width by Goniometric Lens — 0.88 Kappa statistics

Primary: Intraocular Pressure (IOP) at Baseline — 20.51; 20.65 Millimeters of Mercury (mmHg)

Primary: Changes in Vessel Density in Treatment Groups Assessed by OCT Angiography — -0.51; 2.59; -0.96; 0.96 percent change

Primary: Change From Baseline in Intraocular Pressure (IOP) — 22.0; -6.0; 22.0; -6.0 Millimeters of Mercury (mmHg)

Primary: Severity of Ocular Hyperemia in the Study Eye on a 5-Point Scale — 40; 49; 20; 71 Participants

Primary: Mean Change in Intraocular Pressure Between Two Measures- Baseline and 3 Months — -2.3; -6.4 mmHg

Primary: Intraocular Pressure (IOP) at Baseline — 22.04; 22.07 mm Hg

Primary: Incidence of Primary Open-Angle Glaucoma in Hypotensive Patients — 9.5; 4.4; 20.0; 14.1 percent of participants

Primary: Change From Baseline Mean Diurnal Intraocular Pressure (IOP) in the Study Eye on Day 28 — -5.12; -5.94; -5.02; -5.25 mmHg (milimeters of mercury)

Primary: Intraocular Pressure (IOP) in the Study Eye — 16.5; 16.7; 15.7; 16.1 Millimeters of Mercury (mmHg)

Primary: Intraocular Pressure (IOP) at Baseline — 22.0; 22.0 mm Hg

Primary: Severity of Ocular Hyperemia in the Study Eye on a 5-Point Scale — 7; 36; 10; 50 Patients

Primary: Change From Baseline in Intraocular Pressure (IOP) in the Study Eye — 22.2; -6.7 Millimeters of Mercury (mmHg)

Primary: Lamina Cribrosa (Boundaries of the Retinal Layers) Measurements — 264.3; 273.3; 276.2 micro-ohms

Primary: Presence of Retinal Vascular Dysregulation (RVD) — 7; 4 Participants

Primary: Mean Change in Intra-ocular Pressure — -5.30; -5.16; -6.92; -6.57 mmHG

Primary: Mean Change in Intra-ocular Pressure — -4.25; -3.80; -4.22; -4.00 mmHG

Primary: Change From Baseline in Intraocular Pressure (IOP) in the Study Eye — 25.4; -6.3 Millimeters of Mercury (mmHg)

Primary: Decrease From Baseline in Intraocular Pressure — 2.9; 1.6 mmHg

Primary: Change in Intraocular Pressure (IOP) — 38.2; 30.1 percent change

Primary: Safety: Number of Patients Experiencing a Device Related SAE (SADE) and Complications During Implantation — 0; 9; 7 participants

Primary: Safety: Number of Patients Experiencing a Device Related Serious Adverse Events (SADE) and Device Related Adverse Events (ADE) — 0; 0 Participants

Primary: Change From Baseline in Average Eye Intraocular Pressure (IOP) — 25.350; 25.318; 25.341; 24.650 Millimeters of Mercury (mmHg)

Primary: Change From Baseline in Bilateral Intraocular Pressure (IOP) at One Year — 20.8; 20.3; 20.6; -4.8 Millimeters of mercury (mmHg)